November 13, 2012

Voices of IP: Peter Bradley, Innate Immunotherapeutics


Revolutionary Treatments from New Technology
Peter Bradley, Chief Business Development Officer
Auckland, New Zealand

Innate Immunotherapeutics Limited and its 8 employees are dedicated to designing and manufacturing a unique immunomodulator microparticle technology. This technology helps people with multiple sclerosis, cancers and various infectious diseases. Bradley sates that “intellectual property is pivotal” to the development of this technology and to taking their invention to the market and being able to get a return to their investors.

www.IPdelivers.com

  OUR LATEST ON TWITTER

Global Innovation Policy Center (GIPC) @globalIPcenter 3h

“Undermining the protection of #IP — the cornerstone of American ingenuity — is not a solution to income or quality of life differences among countries. It would in fact just serve to make all future generations poorer.” https://t.co/JQfesaM3HQ

Reply Retweet Favorite


Subscribe for updates from GIPC